Tag: Sales

Apr 05, 2019 (Market Exclusive via COMTEX) — Rennova Health, Inc. RNVA, -99.00% Files An 8-K Entry into a Material Definitive Agreement Item 1.01 Entry into a Material Definitive Agreement. In connection with the previously-announced settlement agreement … Rennova Health, Inc. (NASDAQ:RNVA) Files An 8-K Entry into a Material Definitive Agreement Rennova Health, Inc. (NASDAQ:RNVA) […]

Apr 05, 2019 (Market Exclusive via COMTEX) — LINCOLN EDUCATIONAL SERVICES CORPORATION LINC, -1.28% Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain … LINCOLN EDUCATIONAL SERVICES CORPORATION (NASDAQ:LINC) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain […]

… pace and magnitude of the stock market’s rise and equity … shares changed hands on the Nasdaq and the New York … and paltry volumes leaves the stock market at an inflection point … tandem with economic growth. Indeed, stock-market peaks have preceded the start … ‘How is this possible?’ Analysts puzzle over stock […]

Apr 05, 2019 (Market Exclusive via COMTEX) — Moxian, Inc. MOXC, +4.17% Files An 8-K Other Events Item 8.01 On April 5, 2019, Moxian, Inc. (the Registrant)issued a press release announcing that on April 3, 2019 its Board of Directors approved a 1-for-5 … Moxian, Inc. (NASDAQ:MOXC) Files An 8-K Other Events Moxian, Inc. (NASDAQ:MOXC) […]

… NEWSWIRE) — Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement … the Company in accordance with Nasdaq Listing Rule 5635(c)(4 … . About Flexion Therapeutics Flexion Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company … Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) {$excerpt:n}

… NEWSWIRE) — Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical … were approved in accordance with Nasdaq Listing Rule 5635(c)(4 … Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) {$excerpt:n}

… IPO, rather than its competitor Nasdaq. The company filed a public … package, according to the Journal. Nasdaq put up its own fight … the ways that NYSE and Nasdaq have used perks to compete … , and it's profitable Nasdaq, which dominated the tech IPO … NYSE used a massive red banner to […]

… — STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (“STRATA” or the … written notification from The NASDAQ Stock Market (“Nasdaq”) on April 3, 2019 …   This notice from Nasdaq has no immediate effect on … regain compliance with the Nasdaq listing requirements or to … Strata Skin Sciences Receives Notice of Filing Delinquency from […]

… Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct … letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that the … continuing to comply with Nasdaq’s other continued listing … Natural Health Trends Corp. (NASDAQ: NHTC) is an international … Natural Health Trends Receives Non-Compliance Notification Letter from NASDAQ Natural Health Trends Receives […]

… Ascendis Pharma A/S (NASDAQ:ASND) Today, Canaccord Genuity raised … Ascendis Pharma A/S (NASDAQ:ASND) has coverage initiated with … Ascendis Pharma A/S (NASDAQ:ASND) gets upgraded to Outperform … Pharma A/S (NASDAQ:ASND) Shares of Ascendis Pharma … Ascendis Pharma A/S (NASDAQ:ASND) price target raised to 3.00 by Canaccord Genuity Ascendis Pharma A/S (NASDAQ:ASND) price target raised […]